The high expression of CD36, THBS1, and PDK4 in cancer is related to poor prognosis and promotes tumor progression (Guda et al., 2018; Huang et al., 2017; Kim et al., 2019; Liu et al., 2021; Liu et al., 2020; Xu et al., 2019; Zhou et al., 2009). Here, THBS1 is linked to neoplasm.